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Systemic lupus erythematosus (SLE) is a complex autoimmune disorder involving at least hormonal, environmental,
and genetic factors. Familial aggregation, a 2%–3% sibling recurrence rate, monozygotic twin concordance 120%,
association with several candidate genes, as well as the results of five genome scans support a genetic component.
We present here the results of a genome scan of 126 pedigrees multiplex for SLE, including 469 sibling pairs (affected
and unaffected) and 175 affected relative pairs. Using the revised multipoint Haseman-Elston regression technique
for concordant and discordant sibling pairs and a conditional logistic regression technique for affected relative
pairs, we identify a novel linkage to chromosome 4p16-15.2 ( and ) and present evidencePp .0003 LODp 3.84
of an epistatic interaction between chromosome 4p16-15.2 and chromosome 5p15 in our European American
families. We confirm the evidence of linkage to chromosome 4p16-15.2 in European American families using data
from an independent pedigree collection. In addition, our data support the published results of three independent
studies for nine purportedly linked regions and agree with the previously published results from a subset of these
data for three regions. In summary, results from two new analytical techniques establish and confirm linkage with
SLE at 4p16-15.2, indicate epistasis between 4p16-15.2 and 5p15, and confirm other linkage effects with SLE that
have been reported elsewhere.
Introduction
Recent advances in molecular genetics have resulted in
increasingly more detailed physical and genetic maps of
the human genome. As a result, genome scans using large
numbers of highly polymorphic genetic microsatellite
markers to study genetic diseases have become not only
plausible but quite efficient (Lander and Botstein 1989;
Reed et al. 1994). However, as results from genome
scans for complex genetic disorders become available,
the problem of establishing linkage and subsequent gene
identification remains a significant challenge. Studies of
schizophrenia (as reviewed by Tsuang et al. 1999), type
I diabetes (as reviewed by Friday et al. 1999), and sys-
temic lupus erythematosus (SLE [MIM 152700]) ex-
emplify instances in which results vary substantially be-
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tween studies, presumably because of heterogeneity of
sample populations and differing methods of analysis.
SLE is a clinically heterogeneous autoimmune dis-
order that predominantly affects women (∼90%) and
is much more prevalent and severe in African Ameri-
cans, compared with European Americans (Kaslow and
Masi 1978). The etiology of SLE is complex, involving
both environmental and genetic factors and, likely, a
synergistic relationship between the two. High herita-
bility (166%) (Lawrence et al. 1987), increased con-
cordance rates among monozygotic twins (25%–69%),
compared with dizygotic twins and other full siblings
(2%–3%) (Deapen et al. 1992; Reichlin et al. 1992),
familial aggregation (Sestak et al. 1999), association
with multiple candidate genes (as reviewed by Tan and
Arnett 1998), and linkage analysis results from five dif-
ferent genome scans (Moser et al. 1998; Gaffney et al.
1998, 2000; Shai et al. 1999; Lindqvist et al. 2000) all
support a genetic component. Results of cohort-com-
parison studies that include environmental triggers such
as Epstein-Barr virus (James et al. 1997), human T cell
lymphotropic virus (Brand et al. 1999), and hormonal
and chemical exposure (Cooper et al. 1998) support a
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gene-environment interaction, and one cohort-compar-
ison study supports a gene-gene interaction (Mehrian
et al. 1998).
The five genome scans completed to date evaluated
multicase SLE pedigrees collected by investigators in
Oklahoma (Moser et al. 1998), Minnesota (scan I, Gaff-
ney et al. 1998 and scan II, Gaffney et al. 2000), Cal-
ifornia (Shai et al. 1999), and Sweden (Lindqvist et al.
2000). Each used different analysis methods and pop-
ulations. The Minnesota I (MNI), Minnesota II (MNII),
and California (CA) scans used model-free analysis, pri-
marily because their collections were ascertained on the
basis of affected sibling pairs, whereas the Oklahoma
(OK) and Sweden (SW) scans applied model-based tech-
niques to collections composed primarily of extended
multiplex families. TheMNI, MNII, and SW collections
were primarily European American (SW was Icelandic
and Swedish), whereas the original OK collection con-
sisted primarily of European American and African
American pedigrees and the CA collection of European
and Mexican American pedigrees.
After publication of the original OK SLE genome scan
by Moser et al. (1998), the OK collection was expanded
by 32 pedigrees and subsequently was reevaluated in
the present study, using two newly developed model-
free methods. The first method, a revision of the Has-
eman-Elston (HE) regression, evaluated genotypic and
phenotypic information from concordant affected, con-
cordant unaffected, and discordant sibling pairs (Elston
et al. 2000). The other, a conditional logistic regression
technique, used genetic information from affected-rel-
ative pairs (avuncular, grandparental, cousin, and sib-
ling) (Olson 1999b). These methods allowed exploita-
tion not only of the identical-by-descent (IBD) sharing
information between affected pairs—siblings and other
relatives (which are somewhat unique to our lupus ped-
igree collection)—but also of the sharing information
between unaffected and discordant sibling pairs. These
methods also freed the analysis of the limits to identi-
fication of linkages that are often imposed by an a priori
specification of mode of inheritance.
The reevaluation of the expanded OK pedigree col-
lection proved to be a successful application of two new
analytical methods that resulted in identification of a
novel linkage to 4p16-15.2, as well as confirmation of
this linkage in an independent pedigree collection. Re-
sults of this scan identified an epistatic interaction be-
tween chromosome 4p16-15.2 and a candidate region
at 5p15—the first such synergistic relationship to be
shown in family studies of SLE. Finally, results repli-
cated linkage signals at nine regions identified in inde-
pendent studies and four regions identified in a subset
of these data published elsewhere.
Subjects and Methods
Pedigrees
Pedigrees were enrolled in the study only after veri-
fication that at least two members met four or more of
the American College of Rheumatology criteria for clas-
sification for SLE (Tan et al. 1982; Hochberg 1997) and
that the relationship of the affecteds was potentially in-
formative for linkage. After informed consent was ob-
tained, blood samples and/or buccal swabs were col-
lected, and genotypes were obtained for the members of
126 extended multiplex SLE pedigrees, including 744
individuals, 295 of which were classified as affected.
Within these 126 pedigrees were a total of 469 sibling
pairs useful for sibpair analysis, 127 African American
sibling pairs, 297 European American sibling pairs, and
45 sib-pair pedigrees of Asian, Hispanic, Native Amer-
ican, or mixed origin (Other). A total of 175 affected
full-sibling, half-sibling, avuncular, grandparental, and
cousin pairs were included in the affected-relative pair
analysis (table 1).
SLE is found predominantly in women, and, accord-
ingly, our sample is enriched for female versus male af-
fecteds (275:20). Likewise, SLE is more prevalent and
severe in African Americans than in European Ameri-
cans (Alarcon et al. 1999). Our sample, unlike the other
collections mentioned above, is therefore enriched for
African American affecteds (32% African American and
61% European American).
Data from the MNI and MNII pedigree collections
were used to confirm the linkage result on chromosome
4p16-15.2 from the present study. These collections
were 80% and 78% European American, respectively,
and together contained 196 affected full-sibling pairs
(153 European American, 17 African American, and 26
Other), 11 affected half-sibling pairs (6 European Amer-
ican, 4 African American, 1 Other), and 13 affected-
relative pairs other than siblings (13 European Ameri-
can). The procedures for recruitment and genotyping of
these 187 pedigrees (150 European American, 17 Afri-
can American, and 20 Other) have been described else-
where (Gaffney et al. 1998, 2000).
Genotyping
A total of 312 microsatellite markers were typed from
the Version 8 Weber Screening Set, which has an average
marker spacing of 11 cM. PCR was performed in
10.875-ml reaction volumes containing 5–15 ng of tem-
plate DNA, 0.20 mM of M13 tailed primers (Research
Genetics), 0.05 mM of IR40-labeled M13 primer (Li-
Cor), 200 mM of each nucleotide, 10 mM TrisHCl (pH
8.3), 1.50 mM MgCl2, and 0.375 U Taq DNA poly-
merase. Amplified fragments were detected using 6%
polyacrylamide gels electrophoresed on automated Li-
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Table 1
Composition of 126 Multiplex SLE Pedigrees, Separated by Ethnicity
COMPOSITION
ETHNICITY
(No. [%])
TOTAL
African
American
European
American Other
Total multiplex pedigrees 40 (31.7) 77 (61.1) 9 (7.2) 126
Total sib pairs (affected and unaffected) 127 (27.1) 297 (63.3) 45 (9.6) 469
Total nuclear families: 110 (34.7) 174 (54.9) 33 (10.4) 317
% with 1 or 2 sibs 71.8 69.1 75.7
% with 3–5 sibs 26.4 29.8 21.3
% with 15 sib 1.8 1.1 3.0
Total ARPs: 52 (29.7) 112 (64.0) 11 (6.3) 175
% total full sibs 51.9 60.7 63.6
% total half sibs 11.6 1.8 .0
% total other pairs (avuncular,a grandparental, cousin) 36.5 37.5 36.4
a Niece/aunt, niece/uncle, nephew/aunt, and nephew/uncle pairs.
Cor Model 4000 DNA sequencers. Gel images were col-
lected using Base ImagIR software, version 4.0, and al-
leles were determined using the Gene ImagIR program,
version 3.52. The Mammalian Genotyping Center per-
formed initial genotyping of the screening markers for
29 pedigrees in Marshfield, WI (Center for Medical Ge-
netics, Marshfield Medical Research Foundation Web
site), using a fluorescent-based detection system.
Model-Free Linkage Analysis
Prior to any linkage analysis, sibling, half-sibling, and
parent/child relationships were confirmed using statistics
generated by RELTEST (Olson 1999a), a feature of the
S.A.G.E. 4.0 package, version Beta 3 (1999). Multipoint
linkage analysis was performed for all 22 autosomes by
scanning 2-cM increments for linkage to the binary phe-
notype of interest (presence or absence of SLE). Multi-
point IBD-sharing estimates were calculated for each of
the 469 sib pairs. Then, the new HE regression method
(Elston et al. 2000) was performed using the combined
data set, as well as racial subsets of pedigrees (African
American and European American). This method re-
gresses the IBD-sharing values against the mean cor-
rected cross product of the sib-pair trait differences as
— —E[(y  y)(y  y)]p a bp ,i j ij
where yi and yj are the trait values for each sibling in a
pair, is the mean, a is the intercept, b is a parametery¯
estimate, and pij is the IBD sharing value for the ijth
pair. This ordinal measure of the dependent variable al-
lows the phenotype to be treated as if it were continuous.
As seen in the above equation, the correction of the
dependent variable is dependent on a specifiedmean that
is usually calculated from the sampled population. Be-
cause ascertainment bias may be introduced when ped-
igrees are collected on the basis of the presence of the
desired phenotype and therefore may inflate the true
population mean, we chose to analyze our data in two
ways: (1) by defining as the sample mean and (2) byy¯
defining as the population prevalence of disease (∼0).y¯
The results were similar; therefore, all results presented
here were obtained using the correction factor set to¯(y)
the population prevalence of disease, to account (at least
partially) for any ascertainment bias.
In addition, we modeled the covariance of all affected
relative pairs as a function of marker allele–sharing IBD
in the three groups defined above (All, AfricanAmerican,
and European American), using the conditional logistic
formulation implemented in the affected-relative pair
(ARP) subtest (Olson 1999b) of S.A.G.E. 4.0 Beta 3
(1999). This method assesses linkage in affected relative
pairs by constructing the following pair-specific likeli-
hood ratio (LR) statistic:
ˆbi e fri
ip0,1,2LRp ,
bi e fri
ip0,1,2
where is equivalent to , li is the relative risk to
b log li e ie e
an individual who shares i alleles IBD with an affected
relative, fri is the prior probability that a relative pair
(type r) shares i alleles IBD, and is the estimated prob-ˆfri
ability, conditional on the marker data, that a relative
pair (type r) shares i alleles IBD. This LR is then easily
transformed into a LOD score by summation of the base-
10 logarithms of the above pair-specific likelihood ratios.
In addition to information about linkage, the values of
li can also be used to infer mode of inheritance.
Lander and Kruglyak’s criterion for establishing link-
age in complex genetic-disease studies (Lander and
Kruglyak 1995) was applied to all results obtained in
the present analysis. Therefore, any result from the re-
vised HE regression with was considered5P  2# 10
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to have genomewide significance at the 5% level, as was
any result from the conditional logistic regression with
. LOD scores and P values presented are notLOD  3.3
adjusted for genomewide significance; therefore, any re-
gion that meets this criterion is specifically noted as such.
To confirm or refute the evidence of linkage to chro-
mosome 4p16-15.2, we applied the conditional logistic
formulation method to the affected relative pairs in the
combined MNI  MNII pedigree collections. We used
genotypes from the same three microsatellite markers as
those used in the genome scan presented here (D4S2366,
D4S403, and D4S2639).
To address any possible duplication between theMNI
 MNII and the present OK collections, we searched
the genotype data at nine microsatellite markers and
identified seven samples that were genetically identical.
Upon examination of the pedigree structure, race, sex,
and affection status of these samples, it was determined
that five pedigrees were present in both data collections.
These five families were dropped from theMNIMNII
collection prior to analysis.
Multiple regressionmodeling in the AfricanAmerican,
European American, and All groups was conducted, us-
ing the revised HE regression method, to address pos-
sible interaction between regions that were suggestive of
linkage. Three pairwise interactions were assessed for
the European American subset, one for the African
American subset, and three for the entire pedigree
collection.
Finally, to better understand the genetic architecture
of SLE, the locus-specific parameter estimates from the
conditional logistic regression were evaluated for infor-
mation on mode of inheritance (MOI). The parameter
estimates were used to calculate the relative risk of mo-
nozygotic twin, offspring, and other affected relative
pairs (lm, lo, and lr, respectively). Using these relative
risks, we gained insight as to whether the model for that
locus indicated a dominant or recessive MOI. That is,
if ls ( ), the relative risk for a sibling,
1 1 1l p  l  ls o m4 2 4
is approximately equal to lo, then it would appear that
the majority of the affected sibling pairs share only one
allele, and, therefore, the trait would appear dominant
(Risch 1990). On the other hand, if ls were much larger
than lo, then it would appear that a majority of affected
sibling pairs share two alleles and the trait would there-
fore appear recessive (Risch 1990). Of course, these
statements are true only when linkage is present in the
region of interest.
Results
Scanning the genome for linkage using concordant and
discordant sibpairs yielded 20 regions for which signif-
icance at the level spanned, on average, 26 cMP ! .05
(minimum 14, maximum 42). There were 10 regions for
which , 8 for which , and 2.05 1 P 1 .01 .01 1 P 1 .001
for which (table 2). The test for linkage amongP ! .001
the ARPs identified 12 regions in which significance at
a LOD of 1.5 spanned 6–26 cM, with a mean of 13
cM. Six regions were significant at , five atLOD 1 1.5
, and one at (table 2).2.0 ! LOD ! 3.0 LOD 1 3.0
(Please note that all reported P values refer to results
obtained using all possible sibling pairs [SIBPAL2], and
all reported LOD scores refer to results obtained from
ARPs.)
Evidence of Linkage at 4p16-15.2
The effect on chromosome 4p16-15.2 was among the
10 most significant results identified by the original OK
genome scan ( ) (Moser et al. 1998), whichLODp 2.18
used a subset of the same families represented here. The
effect in this region is the most suggestive of linkage in
the European American subset using both the SIBPAL2
( , fig. 1) and ARP ( , fig. 2) meth-Pp .0003 LODp 3.84
ods and is the most significant effect in the entire col-
lection of 126 pedigrees when using ARPs (LODp
). Chromosome 4p16-15.2 is one of only six regions3.44
in the genome scans published to date that meets the
Lander and Kruglyak (1995) threshold of genomewide
significance ( or ) (1q22-245LOD  3.3 P  2# 10
[OK], 1q41 [OK] [Moser et al. 1999; Tsao et al. 1999],
2q37 [SW], 4p16-15.2 [OK], 6p21-11 [MNI  MNII],
and 16q13 [MNI  MNII]).
Linkage to 4p16-15.2 is supported not only by the
magnitude of the effect but also by the replication of
this finding in an independent data collection. The com-
bined MNI  MNII pedigree collection was analyzed
using the conditional logistic, ARP method for the same
microsatellite markers as those used in the present ge-
nome scan (D4S2366, D4S403, and D4S2639). Typing
identical markers in both the OK and MNI  MNII
collections allowed the direct comparison of results and
avoided problems with confirmation that might arise
because of marker variability and mislocalization. A
LOD score of 1.5 was obtained with the European
American ARPs from Minnesota. Although this result
does not meet the Lander and Kruglyak criterion (1995),
it is more than sufficient to be considered a significant
confirmation according to the results of Xu et al. (1999),
which, on the basis of analyses done using data simu-
lated for the Genetic Analysis Workshop 11, state that
a in any one confirmatory study is significantLOD  1.2
confirmation of a linkage effect.
Evidence of linkage to this region was not found in
the African American populations of either the OK
( , ) or MNI MNII ( ) dataPp .99 LODp 0 LODp 0
sets, which therefore suggests that linkage at 4p16-15.2
is specific to the European American subset of pedigrees.
Certainly, this is not the first time that a potentially ra-
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Table 2
Results of or for the OK Scan using SIBPAL2 and ARPs and Results from Other Lupus Genome Scans Significant at theP ! .05 LOD 1 1.5
Confirmatory Level of or and Located within 15 cM of the Microsatellite Used in the OK ScanP ! .05 LOD 1 1.2
REGION
NEAREST
MARKER POPULATION
LOD SCORE;
MODELa
P
LOD SCORE
SIBPAIR SIBPAL2 ARP Independent Studyb
1q22-24c D1S1679 African American .323; DMix .0055 .001 2.47 …
1q22-24c D1S1679 All .470; R50 .035 .009 2.75 …
2p13-11d D2S1777 All .015; R50 … .019 … …
2p13-q12 D2S1790 European American .102; Rmix … .002 … 2.13 (SW)
2q31-34 D2S1391 All .835; R50 .022 .012 … …
2q35-37 D2S1363 All .779; D50 … .024 1.53 1.45 (MNII)
3p21-12 D3S1766 All 1.372; R100 … .020 … …
4p16-15.2c D4S2366 European American 1.657; R100 .0032 .0003 3.84 1.50 (MNI  MNII),e 1.31(MNI  MNII)
4p16-15.2 D4S2366 All 1.385; R100 .0038 .002 3.44 …
4q31-33 D4S2368 European American .809; D50 .05 .004 … 1.02 (MNII)
4q31-33 D4S2368 All 1.221; Rmix .021 .018 … …
5p15 D5S807 European American .927; Dmix … .005 … 1.52 (SW)
5p15 D5S807 All 1.324; Dmix … .0005 1.75 …
6p24-23d D6S2434 All .628; D50 … .006 1.54 …
6p24-23 D6S2434 African American .601; D50 … .009 2.06 1.58 (MNI  MNII)
6p22-21 D6S2439 African American .155; D90 … .011 1.70 1.54 (SW), 1.48(MNII)
6p12-q14 D6S1053 African American 1.186; R50 .007 … 2.36 3.9 (MNI)
7q36 D7S559 European American .538; D50 … .014 … 2.15 (MNII)
7q36 D7S559 All .086; D90 … .023 … …
9p24-21 D9S925 African American .113; Rmix … .004 2.08 …
9q21-32d D9S910 African American .200; R50 … .012 … …
12p12-11c D12S1042 European American 1.946; D50 .014 … 1.79 …
12q24c D12S395 European American 1.802; R50 .004 .009 2.04 …
12q24 D12S395 All 1.795; Rmix .003 .006 … …
17p13.3 D17S1298 European American .690; R50 .03 … 1.57 …
17p11-q21d D17S1299 European American .864; R50 .011 .027 … …
17p11-q21 D17S1299 All .687; Rmix .032 .009 … …
17q21 D17S2180 African American 1.670; Rmix .011 .015 … …
21q21.1 D21S1437 African American .707; D50 … .027 … 1.58 (SW)
21q21.3-22d D21S1440 African American 1.240; R50 .012 .010 … …
a Models used in traditional LOD score analysis, outlined in Moser et al. (1998).
b Results for MNI, MNII, or MNI  MNII were found in the combined pedigree collection (African American and European American),
with the exception of 4p16-15.2, which was specific to the European American families. Results for SW were found in the Swedish families,
with the exception of 21q21.1, which was identified in the Icelandic families.
c Contain loci identified in the same racial group in Moser et al. (1998).
d Linkage signals not previously identified.
e Result obtained using analyses described herein.
cially specific linkage has been observed in the genetic
analysis of SLE family data. Evidence of linkage to 1q22-
24, for example, is the strongest in African Americans
using both the present analysis techniques and the ex-
panded data set ( , ), as well asPp .009 LODp 2.75
using a traditional LOD-score method with either all
126 pedigrees ( ) or a subset of the presentLODp 3.97
data ( ) (Moser et al. 1998). However, thisLODp 3.45
effect is much less significant in the EuropeanAmericans,
regardless of method of analysis or size of data set. Ra-
cially specific linkages may account, at least in part, for
the difficulty in replication of results between pedigree
collections.
Using the parameter estimates produced by the con-
ditional logistic regression technique, the mode of in-
heritance for the linkage at 4p16-15.2 was inferred for
both the OK and theMNIMNII data sets. The relative
risk estimates (ls) for affected sibling pairs were 2.16
and 1.22 at the peak of the linkage signal for the OK
and MN data sets, respectively. The relative risk esti-
mates for affected parent–offspring pairs (lo) were 1.62
and 1.00, respectively. Because the sibling sharing esti-
mates (ls) were approximately equal, in both pedigree
collections, to that of the parent-offspring sharing esti-
mate (lo), the linkage at 4p16-15.2 appears to follow a
dominant rather than a recessive mode of inheritance.
Identification of Epistasis at 4p16-15.2
Choosing from those regions considered to be sug-
gestive of linkage in the expanded OK pedigree collec-
tion, we identified six regions with which to perform
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Figure 1 Chromosomes containing regions with SIBPAL2 significance !.01. Centimorgans are plotted on the X-axis and P values on the
Y-axis. Asterisks(*) indicate locations of other linkage signals identified on chromosomes 4 and 6 (Gaffney et al. 1998; Lindqvist et al. 2000).
multiple-regression modeling (only results from the re-
vised HE regression were considered, since it is with this
method that we would assess interaction) (table 3). In-
clusion in the multiple-regression modeling was based
on both the magnitude ( ) of the result and sup-P ! .01
port from previous studies (table 2). There were three
regions chosen in the European American subset (4p16-
15.2, 4p31-33, and 5p15), two in the African American
subset (1q22-24 and 6p23-22), and three in the com-
bined set (1q22-24, 5p15, and 6p24-23).
The European American subset model, including
4p16-15.2 ( ), 5p15 ( ), and their in-Pp .343 Pp .591
teraction (4p16-15.2# 5p15), indicated amultiplicative
relationship between the two regions. In addition to a
significant P value for the interaction term in the model
( ), the parameter estimates (relative variancePp .038
component measures) for the main effects in the presence
of the interaction term also support an interaction. Be-
cause the relative variance components for the main ef-
fects (individual regions) are much less than that of the
interaction (.0737, .000, and .3095, respectively), the
global variance in the model can be attributed almost
entirely to the interaction.
Identification of New Candidate Linkages
Three regions identified in this genome scan and sig-
nificant at had not been explicitly identified else-P ! .01
where. The effects on chromosome 12q24 in the Eu-
ropean American subset ( , ) andPp .009 LODp 2.04
on chromosome 17p11-q21 in all 126 pedigrees (Pp
) are unique to the present study and are not in the.009
proximity of other signals that have been identified else-
where. The effect on chromosome 6p24-23 (table 2,
), found when analyzing all 126 pedigrees to-Pp .006
gether, is within 10 cM of a region originally identified
in the MNI scan (6p21-11) (Gaffney et al. 1998) (figs.
1 and 2). Although a definitive conclusion regarding
the independence of the effects on chromosome 6p can-
not yet be made, fine-mapping studies and multipoint
analyses of this region should aid in making this
determination.
Significant Effects Identified Elsewhere
Results from the present scan support linkage in 10
regions identified in independent studies elsewhere
(MNI, MNII, and SW) (table 2). The effect on chro-
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Figure 2 Chromosomes containing regions with ARP LOD scores 12.0. Centimorgans are plotted on the X-axis and LOD scores on the
Y-axis. Asterisks (*) indicate locations of other linkage signals identified on chromosomes 4 and 6 (Gaffney et al. 1998; Lindqvist et al. 2000).
mosome 5p15, the most significant result in the com-
bined data set for SIBPAL2 ( , fig. 1) and ARPsPp .0005
( , table 2) was identified independently inLODp 1.75
the SW scan (Lindqvist et al. 2000) (table 2). It is im-
portant to note that, although the effect on chromosome
5p15 is not the largest in magnitude for the combined
data set, it remains the only effect that cannot be pre-
dominantly attributed to the effect of either the African
American or European American subset. One region,
6p22.1-21, was identified in the present study, as well
as in the SW (Lindqvist et al. 2000) and MNII (Gaffney
et al. 2000) scans (table 2). Not suprisingly, this region
encompasses HLA components such as C2, C4A, C4B,
HLA-B, HLA-DR, and HLA-DQ, all of which have been
associated with SLE in cohort-comparison studies (Schur
et al. 1982).
The most suggestive linkage effect in the African
American subset for each of the methods used in the
present study was 1q22-24 ( , fig. 1;Pp .001 LODp
, fig. 2). This region, like 4p16-15.2, was identified2.47
in the original OK scan (Moser et al. 1998). In fact,
1q22-24 overlaps a region containing several candidate
genes, one of which, FcgRIIA, is the most significant
single-point linkage result for the African American
subset in the aforementioned scan ( ) (seeLODp 3.37
Moser et al. 1998). The magnitude of the results ob-
tained at 1q22-24 in the present analyses did not vary
greatly with the addition of the FcgRIIA candidate gene
into the multipoint analysis ( , ).Pp .004 LODp 2.36
The identification of new linkage signals, as well as
increased evidence for linkage to previously detected
regions, could be attributable to the increase in sample
size from the original OK data set to the current. How-
ever, a traditional LOD-score and sib-pair screen of the
expanded collection (methods outlined in Moser et al.
1998) either failed to detect or detected at a lesser sig-
nificance level all regions except those on chromosome
12 and 17, which are similar in significance across meth-
ods (table 2).
Discussion
The results of this study support the presence, in Eu-
ropean American populations, of an SLE susceptibility
locus on chromosome 4p16-15.2. The results further
support the involvement of this susceptibility locus in a
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Table 3
Results of Models Using One Marker (Single Regression) and Two
Markers with Their Interaction (Multiple Regression) for the
Concordant and Discordant Sibling Pairs in the Expanded OK
Pedigree Collection
PEDIGREE SUBSET AND REGION
PARAMETER ESTIMATES
P
Single
Regression
Multiple
Regression
European American:
4p16-15.2 .2250 .1577 .1050
4q31-33 .1576 .0736 .3020
4p16-15.2 # 4q31-33 .1083 .3150
4p16-15.2 .2250 .0737 .3430
5p15 .1660 .0000 .5910
4p16-15.2 # 5p15 .3095 .0380
4q31-33 .1576 .1429 .1140
5p15 .1660 .1541 .0990
4q31-33 # 5p15 .0526 .4000
African American:
1q22-24 .3149 .3008 .0440
6p24-23 .2650 .2454 .0780
1q22-24 # 6p23-22 .0000 .6060
All pedigrees:
1q22-24 .1332 .1202 .0320
6p24-23 .1309 .1767 .0360
1q22-24 # 6p24-23 .0000 .7640
1q22-24 .1332 .1311 .0020
5p15 .1733 .1304 .0002
1q22-24 # 5p15 .0000 .9840
6p24-23 .1309 .0739 .2390
5p15 .1733 .1317 .1050
6p24-23 # 5p15 .1770 .3010
synergistic relationship with a potential susceptibility lo-
cus on chromosome 5p15 in an European American
population. Finally, results support the continued ap-
plication of these analytical methods to both new and
previously collected pedigree data for the purposes of
identifying previously undetected linkage signals and
confirming strong but previously unreplicated results.
The results of two previous genome scans suggest
linkage of SLE to chromosome 4. Gaffney et al. (2000)
identified a moderate linkage signal at D4S424
( ), and Lindqvist et al. (2000) presentedLODp 1.50
evidence of linkage to D4S1627 ( ). How-LODp 3.20
ever, both of these signals appear independent of the
novel linkage mapped to 4p16-15.2 (figs. 1 and 2).
D4S424 has been localized to 4q33, a band on the long
arm of chromosome 4 and 1150 cM from 4p16-15.2.
D4S1627, although labeled in the SW scan as 4p15, has
actually been localized to 4p13, the most telomeric band
on the short arm of chromosome 4 and is 140 cM from
4p16-15.2. (Marker localization is according to the fol-
lowing standardized genetic databases: Center for Med-
ical Genetics, MarshfieldMedical Research Foundation;
Cooperative Human Linkage Center; Genome Data-
base; LDB, Genetic Location Database; and Whitehead
Institute for Biomedical Research/MIT Center for Ge-
nome Research.)
The novel linkage identified at chromosome 4p16-
15.2 is among the most convincing candidate linkages
in lupus to date. Although the evidence (LODp 3.84
and 1.5) is quite different for the OK and MNIMNII
collections respectively, it is typical for a confirmatory,
targeted marker study (as opposed to a genome screen),
to have a smaller effect, since no selection was made
on the basis of the magnitude of the result. Accordingly,
this effect both exceeds the threshold of setLODp 3.3
by Lander and Kruglyak (1995) for the data set in which
it was first identified, as well as exceeds the LODp
criteria touted as necessary for confirmation by Xu1.2
et al. (1999). It is one of only six SLE candidate linkages
that are significant at (Lander and Krug-LODp 3.3
lyak 1995) (1q22-24 [OK], 1q41 [OK, UCLA] [Tsao et
al. 1999]), 2q37 (SW), 4p16-15.2 (OK), 6p21-11 (MNI
MNII), and 16q13 (MNIMNII) and is one of only
three regions to also meet the confirmation criterion set
forth by Xu et al. (1999) (1q41[OK, UCLA, MNI 
MNII], 4p16-15.2 (OK and MNI MNII), and 6p21-
11 (MNI  MNII, OK, SW).
Almost 70 genes are currently mapped to chromo-
some 4p16-15.2, 21 of which have either been associ-
ated with an autoimmune disease or appear to be po-
tentially involved in autoimmune processes. This set
includes several genes that are directly involved with B
and T lymphocyte activity—namely, CD38, BST1,
ZNF36, ZNF134, and ZNF136. Furthermore, a gene
linked to lupus nephritis in an NZBxW murine model
system (sle6) maps to the centromeric region of mouse
chromosome 5 (Morel et al. 1999). This region is
syntenic to human chromosome 4p16-15 (placement
based on the standardized Mouse Genome Informatics
database).
All complex genetic diseases potentially involve gene-
gene interactions, at least to some extent. SLE is no
exception. One such interaction between IL-10 and bcl-
2 was proposed (Mehrian et al. 1998) on the basis of
cohort comparison, but a gene-gene interaction based
on family data has not yet been identified. However, we
present the first evidence to date of a locus-locus inter-
action involved in lupus. Although a biological model
underlying this interaction cannot be determined at this
time, we propose, on the basis of the modeling tech-
niques used, that the relationship between markers at
4p16-15.2 and 5p15 is epistatic rather than additive in
nature.
The possibility that there are several potential SLE
loci yet to be identified is only reinforced by the con-
tinued identification of new candidate linkages. For ex-
ample, three regions that were not identified by the
five preceding scans (Moser et al. 1998; Gaffney et al.
1998, 2000; Shai et al. 1999; Lindqvist et al. 2000)
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were found to be significant at (6p24-23, 12q24,P ! .01
and 17p11-q21) and (2p13-11, 9p24-21, andP ! .05
21q21.3-22) in the present analysis (table 2). Certainly,
increased type I–error rates must be considered as the
number of analyses increase. However, identification of
new candidate regions such as those found in the present
scan are perhaps a result of not only increased sample
size but also improved analytical techniques that better
maximize the information available from multiplex
pedigrees.
In attempting to reconcile the various results from
genetic-linkage studies of SLE, one must consider the
clinical heterogeneity of the disease. SLE is highly var-
iable among individual patients and, to some extent,
between ethnic groups, since certain disease manifes-
tations seem to cluster within racial populations,
whereas others do not (Petri 1998). It is therefore not
unreasonable to believe that there are genes specific to
either a particular racial group or to a particular clinical
manifestation. Work by S. Rao, J. M. Olson, C. Gray-
McGuire, G. R. Bruner, J. Kelly, K. L. Moser, and J. B.
Harley (unpublished data), using the expanded OK col-
lection, assesses linkage to various clinical manifesta-
tions of SLE and compares the occurrence of those man-
ifestations both between and within families. The results
of this study show that there are indeed linkages to
particular lupus manifestations, without regard to racial
affiliation. This suggests that the inability to replicate a
result within a particular racial subset does not neces-
sarily refute linkage at that locus to lupus but, instead,
could indicate a linkage that is specific to a phenotypic
rather than a racial subset.
These results (table 2) also illustrate the dependence
of many of the traditional linkage methods on prior
knowledge of genetic mechanism. For example, 4p16-
15.2, a region where linkage has now been established
and confirmed, was not found at this magnitude, even
in the same data set, using other methods. Certainly, it
is no surprise that results differ by method applied, and,
although there is a statistical penalty that should be
considered when applying multiple methods to the same
set of marker data, the results herein support the view
that important linkages may be missed when analysis
is restricted to a single method.
In conclusion, results of this genome scan support the
involvement of a SLE susceptibility locus on chromo-
some 4p16-15.2 in an European American population.
This result reaches a significance level attained by only
one other lupus candidate linkage to date. Our results
support an epistatic relationship between this suscep-
tibility locus and a potential susceptibility locus on chro-
mosome 5p15. Finally, although a discussion of the
power of the methods used in this scan is beyond the
scope of this paper, results do support the application
of these and other new techniques to previously col-
lected and recently expanded pedigree collections both
to identify new candidate linkages and to confirm strong
but unacknowledged linkages.
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